Pieris Pharmaceuticals Income from Continuous Operations 2014-2024 | PVLA
Pieris Pharmaceuticals income from continuous operations from 2014 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change